Business Description
Ampio Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US03209T1097
Description
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee ("OAK") as part of its OA-201 development program ("OA-201 program" or "OA-201").
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.92 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 23 | |||||
| 3-Year EPS without NRI Growth Rate | 26.7 | |||||
| 3-Year FCF Growth Rate | 25.6 | |||||
| 3-Year Book Growth Rate | 30.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.48 | |||||
| 9-Day RSI | 38.11 | |||||
| 14-Day RSI | 43.04 | |||||
| 6-1 Month Momentum % | -99.12 | |||||
| 12-1 Month Momentum % | -99.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.41 | |||||
| Quick Ratio | 2.41 | |||||
| Cash Ratio | 1.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 55.8 | |||||
| Shareholder Yield % | 16450 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -123.45 | |||||
| ROA % | -92.12 | |||||
| ROIC % | -2277.03 | |||||
| ROC (Joel Greenblatt) % | -3436.1 | |||||
| ROCE % | -132.75 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 0.4 | |||||
| EV-to-EBITDA | 0.4 | |||||
| EV-to-FCF | 0.45 | |||||
| Earnings Yield (Greenblatt) % | 250 | |||||
| FCF Yield % | -285466.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AMPE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ampio Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -11.01 | ||
| Beta | 5.86 | ||
| Volatility % | 2130.7 | ||
| 14-Day RSI | 43.04 | ||
| 14-Day ATR ($) | 0.003804 | ||
| 20-Day SMA ($) | 0.00393 | ||
| 12-1 Month Momentum % | -99.89 | ||
| 52-Week Range ($) | 0.0001 - 7.47 | ||
| Shares Outstanding (Mil) | 1.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ampio Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ampio Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ampio Pharmaceuticals Inc Frequently Asked Questions
What is Ampio Pharmaceuticals Inc(AMPE)'s stock price today?
The current price of AMPE is $0.00. The 52 week high of AMPE is $7.47 and 52 week low is $0.00.
When is next earnings date of Ampio Pharmaceuticals Inc(AMPE)?
The next earnings date of Ampio Pharmaceuticals Inc(AMPE) is 2024-12-02 Est..
Does Ampio Pharmaceuticals Inc(AMPE) pay dividends? If so, how much?
Ampio Pharmaceuticals Inc(AMPE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers